Viemed Healthcare (VMD) Revenue Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.52% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.14% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.92% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.43% |
| 10 | Viemed Healthcare | 373.53 Mn | 365.70 Mn | 42.83 Mn | 24.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.00% |
| Dec 31, 2025 | 26.64% |
| Sep 30, 2025 | 26.22% |
| Jun 30, 2025 | 23.70% |
| Mar 31, 2025 | 22.39% |
| Dec 31, 2024 | 23.83% |
| Sep 30, 2024 | 25.58% |
| Jun 30, 2024 | 26.12% |
| Mar 31, 2024 | 21.20% |
| Dec 31, 2023 | 17.59% |
| Sep 30, 2023 | 13.88% |
| Jun 30, 2023 | 0.35% |
| Mar 31, 2023 | 18.44% |
| Dec 31, 2022 | 20.48% |
| Sep 30, 2022 | 20.64% |
| Jun 30, 2022 | 17.90% |
| Mar 31, 2022 | 21.20% |
| Dec 31, 2021 | 20.29% |
| Sep 30, 2021 | 20.04% |
| Jun 30, 2021 | 21.68% |
| Mar 31, 2021 | 26.72% |